| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| F Sánchez-Sánchez, B Ponce-Buj, A L Montejo-González, Y Sipán-Sarrión, A Gimeno-Marqués, A Merino-Gáme. [Impact of vortioxetine on sexual function compared to other antidepressants]. Semergen. vol 49. issue 7. 2023-06-17. PMID:37329592. |
to analyze the impact of the antidepressant vortioxetine on sexual function, compared to selective serotonin reuptake inhibitors (ssris) and mixed selective serotonin and norepinephrine reuptake inhibitors (irsn or dual) in patients with depression. |
2023-06-17 |
2023-08-14 |
Not clear |
| Marie Spies, Matej Murgaš, Chrysoula Vraka, Cecile Philippe, Gregor Gryglewski, Lukas Nics, Theresa Balber, Pia Baldinger-Melich, Annette M Hartmann, Dan Rujescu, Marcus Hacker, Edda Winkler-Pjrek, Dietmar Winkler, Rupert Lanzenberge. Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo. Translational psychiatry. vol 13. issue 1. 2023-06-15. PMID:37322010. |
variants within the monoamine oxidase a (mao-a, maoa) and tryptophan hydroxylase 2 (tph2) genes, the main enzymes in cerebral serotonin (5-ht) turnover, affect risk for depression. |
2023-06-15 |
2023-08-14 |
human |
| Rif S El-Mallakh, Masoud Doroodgar, Omar H Elsayed, Neil Kidamb. The serotonin theory of depression. Molecular psychiatry. 2023-06-15. PMID:37322061. |
the serotonin theory of depression. |
2023-06-15 |
2023-08-14 |
Not clear |
| Lucie Bartova, Rupert Lanzenberger, Dan Rujescu, Siegfried Kaspe. Reply to: "The serotonin theory of depression: a systematic umbrella review of the evidence" published by Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA in Molecular Psychiatry (2022 Jul 20. doi: 10.1038/s41380-022-01661-0). Molecular psychiatry. 2023-06-15. PMID:37322062. |
reply to: "the serotonin theory of depression: a systematic umbrella review of the evidence" published by moncrieff j, cooper re, stockmann t, amendola s, hengartner mp, horowitz ma in molecular psychiatry (2022 jul 20. doi: 10.1038/s41380-022-01661-0). |
2023-06-15 |
2023-08-14 |
Not clear |
| Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael P Hengartner, Martin Plöderl, Mark A Horowit. The serotonin hypothesis of depression: both long discarded and still supported? Molecular psychiatry. 2023-06-15. PMID:37322064. |
the serotonin hypothesis of depression: both long discarded and still supported? |
2023-06-15 |
2023-08-14 |
Not clear |
| Shuchang Zhao, Kiryl D Piatkevic. Techniques for in vivo serotonin detection in the brain: State of the art. Journal of neurochemistry. 2023-06-09. PMID:37293767. |
disruptions in serotonin signaling underlie neuropsychiatric conditions such as depression and anxiety. |
2023-06-09 |
2023-08-14 |
Not clear |
| Carla S S Ferreira, Sandra C Soares, Peter Kille, Miguel Oliveir. Identifying knowledge gaps in understanding the effects of selective serotonin reuptake inhibitors (SSRIs) on fish behaviour. Chemosphere. 2023-06-07. PMID:37285976. |
selective serotonin reuptake inhibitors (ssris) are a class of antidepressants increasingly prescribed to treat patients with clinical depression. |
2023-06-07 |
2023-08-14 |
Not clear |
| Soichiro Kitamura, Yasuyuki Kimura, Keisuke Takahata, Sho Moriguchi, Manabu Kubota, Hitoshi Shimada, Hironobu Endo, Yuhei Takado, Kazunori Kawamura, Ming-Rong Zhang, Tetsuya Suhara, Makoto Higuch. Serotonergic neurotransmission in limbic regions may reflect therapeutic response of depressive patients: A PET study with 11C-WAY-100635 and 18F-MPPF. The international journal of neuropsychopharmacology. 2023-06-06. PMID:37279545. |
central serotonin (5-hydroxytryptamine, 5-ht) neurotransmission has been implicated in the etiology of depression. |
2023-06-06 |
2023-08-14 |
Not clear |
| Dilpreet Singh, G D Gupt. A Complete Sojourn of Gene Therapy Along with its Targeting Approaches for the Treatment of the Major Depressive Disorder. Current gene therapy. 2023-06-02. PMID:37264624. |
depression has been linked to the malfunctioning of serotonin signaling genes, including p11, sert, etc, according to earlier research. |
2023-06-02 |
2023-08-14 |
Not clear |
| Mark Slifstein, Anissa Abi-Dargha. Detecting Pharmacologically Induced Serotonin Release in Depression With Positron Emission Tomography Imaging: A New Approach. Biological psychiatry. vol 93. issue 12. 2023-05-31. PMID:37257982. |
detecting pharmacologically induced serotonin release in depression with positron emission tomography imaging: a new approach. |
2023-05-31 |
2023-08-14 |
Not clear |
| Jinli Zhang, Xiaohui Zheng, Zhenying Zha. A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease. BMC neurology. vol 23. issue 1. 2023-05-31. PMID:37259037. |
a systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in alzheimer's disease. |
2023-05-31 |
2023-08-14 |
Not clear |
| S M Nageeb Hasan, Courtney Leigh Clarke, Tadhg Patrick McManamon Strand, Francis Rodriguez Bambic. Putative pathological mechanisms of late-life depression and Alzheimer's Disease. Brain research. 2023-05-27. PMID:37244602. |
ad and depression share common pathophysiologies, including functional deficits of the serotonin (5-ht) system. |
2023-05-27 |
2023-08-14 |
Not clear |
| Huijuan Liao, David S Rosenthal, Salini C Kuma. Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment. Case reports in psychiatry. vol 2023. 2023-05-23. PMID:37215167. |
selective serotonin reuptake inhibitors (ssris) are often prescribed for depression. |
2023-05-23 |
2023-08-14 |
Not clear |
| Shatha Subhi ALHarthi, Munerah S BinShabaib, Abdulrahman Alwahibi, Shahinaz Gamal, Eldin Elashiry, Sarah E Almershed, Haifa Abdulrahman Alkhamis, Lamyia Anweig. Periodontal and peri-implant status and whole salivary interleukin 1-beta levels among individuals using selective serotonin reuptake inhibitors: an observational study. BMC oral health. vol 23. issue 1. 2023-05-22. PMID:37217913. |
selective serotonin reuptake inhibitors (ssri) are commonly used for managing psychological diseases such as depression. |
2023-05-22 |
2023-08-14 |
human |
| Makoto Kond. Molecular Mechanisms of Exercise-induced Hippocampal Neurogenesis and Antidepressant Effects. JMA journal. vol 6. issue 2. 2023-05-14. PMID:37179732. |
it has been reported that exercise has preventive effects on depression (antidepressant effects) and that serotonin, whose release increases in the brain with exercise, is involved in exercise-induced antidepressant effects. |
2023-05-14 |
2023-08-14 |
mouse |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
serotonin and depression: scrutiny of new targets for future anti-depressant drug development. |
2023-05-12 |
2023-08-14 |
Not clear |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
the "serotonin hypothesis of depression" is approximately fifty years old, and in spite of vast literature, the exact role of serotonin in depression pathophysiology is still unclear, as whether a lower serotonin level causes depression or depression causes a reduction in serotonin level has become a tough challenge for researchers to understand the actual involvement of serotonin in depression. |
2023-05-12 |
2023-08-14 |
Not clear |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
several pre-clinical and clinical studies have illustrated the multi-faceted signalling action of serotonin in depression and vouch for the significant or unavoidable role of serotonin in depression. |
2023-05-12 |
2023-08-14 |
Not clear |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
in this review, the journey of the serotonin hypothesis of depression from the 1950s to the present time has been analysed to understand the serotonin hypothesis of depression and investigate the new molecular targets for the development of new future anti- depressants. |
2023-05-12 |
2023-08-14 |
Not clear |
| Arzoo Pannu, Ramesh K Goya. Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets. 2023-05-12. PMID:37170981. |
the old and new theories of possible cellular mechanisms found to be involved in the pathophysiology of major depression or stress, such as polymorphism of serotonin transporters, enzyme modulating serotonergic activity, reduction in the level of serotonin and involvement of different sub-types of receptors, have been discussed in the respective review. |
2023-05-12 |
2023-08-14 |
Not clear |